Oncology
The bystander effect of TRAIL gene therapy relies on cell-to-cell contact
Published in Cancer Weekly, July 15th, 2003
"We have previously reported that direct transfer of the TNF-related apoptosis-inducing ligand (TRAIL) gene resulted in an apoptotic bystander effect, and that this bystander effect was not transferable with cell culture media. To further characterize its mechanism we tested the bystander effect of TRAIL in the human ovarian cancer cell line DOV13, human lung cancer cell line A549, human hepatoma cell line Hepa G2, human breast cancer cell line MDA-MB231 and human colon cancer cell lines Lovo and DLDL," wrote X.F. Huang and colleagues, University of Texas, M.D. Anderson Cancer Center.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-07-15)
More Articles from Cancer Weekly
- Apoptosis
Researchers find new way to trigger self-destruction of certain cancer cells - Cancer Metastasis
Rogue genes speed breast cancer spread to bone marrow - Cancer Vaccine
Vaccine against carcinoembryonic antigen does not induce autoimmunity - Colon Carcinoma
Malignant colon cells had 42 gastrin-releasing peptide receptor gene mutations - Leukemia
Stem cell factor mobilization improves stem cell graft efficacy - Squamous Cell Carcinoma
Heparanase level linked to cancer invasiveness, basement membrane destruction - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
